JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
TBPH - Theravance Biopharma, Inc.
USD | NASDAQ | Healthcare
Summary
Summary TBPH Stock
Financials
Financials TBPH Stock
Loading...
Loading...
Income Statement
Income Statement TBPH Stock
Balance Sheet
Balance Sheet TBPH Stock
Cash Flow Statement
Cash Flow Statement TBPH Stock
Loading...
Loading...
Home
Stocks
Theravance Biopharma, Inc. (TBPH)
Financials
Financials of TBPH
Loading...
Loading...
Loading...
Loading...
TBPH Financials - Theravance Biopharma Income & Cash Flow | Ledgeburg
Revenue
$107.464M
Operating Income
$-3.602M
Net Income
$105.895M
Share Count (Basic)
50.317M
Operating Cash Flow
$238.541M
Free Cash Flow
$238.499M
Cash And Short-Term Equivalents
$167.806M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
80M
100M
FY2021
FY2022
FY2023
Revenue $USD
0
10M
20M
30M
40M
50M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Annual
Quarterly
Net Income $USD
-200M
0
200M
400M
600M
800M
Annual
Quarterly
Margins
Gross
Operating
Net
-500%
0%
500%
1000%
1500%
FY2024
FY2025
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-20M
0
20M
40M
60M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-100%
0%
100%
200%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26